New CEO at Ipsen
David Loew, formerly executive vice president of Sanofi Pasteur, was appointed as CEO of French Ipsen Pharma SA at the beginning of July.
Loew will taking over from interim CEO Aymeric Le Chatelier, who was serving after David Meeks departure at the end of 2019. Le Chatelier will continue his role of Chief Financial Officer.
He started at Roche in 1992 and held a variety of positions, including Global Oncology Head, Global Chief Marketing Officer & Head of Global Product Strategy and Region Head Eastern Europe, Middle East and Africa for the Pharma Division of Roche. In July 2013 he joined Sanofi as Senior Vice President Commercial Operations Europe. In 2016 he was appointed as CEO of Sanofis vaccine unit Sanofi Pasteur. He left the company due to management changes by the new Sanofi-CEO Paul Hudson.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium